Stem cell therapy

Stem cell therapy, in particular the use of mesenchymal stromal cells (MSCs) is a potential treatment that has been suggested for ME/CFS.

Theory

iDC, immature dendritic cell; IL, interleukin;
HGF, hepatocyte growth factor;
TGF-β, transforming growth factor-β;
PGE-2, prostaglandin E2; IDO, indoleamine-2,3-dioxygenase;
NO, nitric oxide; PD-L1, programmed death-ligand 1;
hMSC, human mesenchymal stem cell;
Treg, T regulatory; Th, T helper cell
CTL, cytotoxic T cell; mDC, mature dendritic cell
PD-1, programmed cell death protein ;1
PMN, polymorphonuclear leukocyte;
NK, Natural killer cell

Evidence

Clinical trials of stem cell therapies have not yet been published.

See also

• Immune system
• Metabolic trap
• Indoleamine-2,3-dioxygenase
• Interleukin
• transforming growth factor-β;
• Nitric oxide
• T regulatory
• T helper cell
• Cytotoxic T cell
• Natural killer cell

Learn more

• Culturing Adult Stem Cells for Cell-Based Therapeutics: Neuroimmune Applications

β β / Β. Greek letter beta (a symbol used in science), equivalent to "b".

indoleamine (IDO) - any derivatives of an indole (e.g., serotonin, tryptophan) that contain an amine group

indole (IDO) - a signalling molecule produced by bacteria as a result of metabolising tryptophan, found in the intestines

apoptosis a type of cell death in which a cell, in response to a threat, initiates a series of molecular steps that lead to its orderly death. This is one method the body uses to get rid of unneeded or abnormal cells. This form of cell suicide is also called programmed cell death.